A COVID‐19‐ready public health surveillance system: The Food and Drug Administration's Sentinel System
The US Food and Drug Administration's Sentinel System was established in 2009 to use routinely collected electronic health data for improving the national capability to assess post‐market medical product safety. Over more than a decade, Sentinel has become an integral part of FDA's surveil...
Saved in:
| Published in | Pharmacoepidemiology and drug safety Vol. 30; no. 7; pp. 827 - 837 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Chichester, UK
John Wiley & Sons, Inc
01.07.2021
Wiley Subscription Services, Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1053-8569 1099-1557 1099-1557 |
| DOI | 10.1002/pds.5240 |
Cover
| Abstract | The US Food and Drug Administration's Sentinel System was established in 2009 to use routinely collected electronic health data for improving the national capability to assess post‐market medical product safety. Over more than a decade, Sentinel has become an integral part of FDA's surveillance capabilities and has been used to conduct analyses that have contributed to regulatory decisions. FDA's role in the COVID‐19 pandemic response has necessitated an expansion and enhancement of Sentinel. Here we describe how the Sentinel System has supported FDA's response to the COVID‐19 pandemic. We highlight new capabilities developed, key data generated to date, and lessons learned, particularly with respect to working with inpatient electronic health record data.
Early in the pandemic, Sentinel developed a multi‐pronged approach to support FDA's anticipated data and analytic needs. It incorporated new data sources, created a rapidly refreshed database, developed protocols to assess the natural history of COVID‐19, validated a diagnosis‐code based algorithm for identifying patients with COVID‐19 in administrative claims data, and coordinated with other national and international initiatives.
Sentinel is poised to answer important questions about the natural history of COVID‐19 and is positioned to use this information to study the use, safety, and potentially the effectiveness of medical products used for COVID‐19 prevention and treatment. |
|---|---|
| AbstractList | The US Food and Drug Administration's Sentinel System was established in 2009 to use routinely collected electronic health data for improving the national capability to assess post‐market medical product safety. Over more than a decade, Sentinel has become an integral part of FDA's surveillance capabilities and has been used to conduct analyses that have contributed to regulatory decisions. FDA's role in the COVID‐19 pandemic response has necessitated an expansion and enhancement of Sentinel. Here we describe how the Sentinel System has supported FDA's response to the COVID‐19 pandemic. We highlight new capabilities developed, key data generated to date, and lessons learned, particularly with respect to working with inpatient electronic health record data.
Early in the pandemic, Sentinel developed a multi‐pronged approach to support FDA's anticipated data and analytic needs. It incorporated new data sources, created a rapidly refreshed database, developed protocols to assess the natural history of COVID‐19, validated a diagnosis‐code based algorithm for identifying patients with COVID‐19 in administrative claims data, and coordinated with other national and international initiatives.
Sentinel is poised to answer important questions about the natural history of COVID‐19 and is positioned to use this information to study the use, safety, and potentially the effectiveness of medical products used for COVID‐19 prevention and treatment. The US Food and Drug Administration's Sentinel System was established in 2009 to use routinely collected electronic health data for improving the national capability to assess post‐market medical product safety. Over more than a decade, Sentinel has become an integral part of FDA's surveillance capabilities and has been used to conduct analyses that have contributed to regulatory decisions. FDA's role in the COVID‐19 pandemic response has necessitated an expansion and enhancement of Sentinel. Here we describe how the Sentinel System has supported FDA's response to the COVID‐19 pandemic. We highlight new capabilities developed, key data generated to date, and lessons learned, particularly with respect to working with inpatient electronic health record data. Early in the pandemic, Sentinel developed a multi‐pronged approach to support FDA's anticipated data and analytic needs. It incorporated new data sources, created a rapidly refreshed database, developed protocols to assess the natural history of COVID‐19, validated a diagnosis‐code based algorithm for identifying patients with COVID‐19 in administrative claims data, and coordinated with other national and international initiatives. Sentinel is poised to answer important questions about the natural history of COVID‐19 and is positioned to use this information to study the use, safety, and potentially the effectiveness of medical products used for COVID‐19 prevention and treatment. The US Food and Drug Administration's Sentinel System was established in 2009 to use routinely collected electronic health data for improving the national capability to assess post-market medical product safety. Over more than a decade, Sentinel has become an integral part of FDA's surveillance capabilities and has been used to conduct analyses that have contributed to regulatory decisions. FDA's role in the COVID-19 pandemic response has necessitated an expansion and enhancement of Sentinel. Here we describe how the Sentinel System has supported FDA's response to the COVID-19 pandemic. We highlight new capabilities developed, key data generated to date, and lessons learned, particularly with respect to working with inpatient electronic health record data. Early in the pandemic, Sentinel developed a multi-pronged approach to support FDA's anticipated data and analytic needs. It incorporated new data sources, created a rapidly refreshed database, developed protocols to assess the natural history of COVID-19, validated a diagnosis-code based algorithm for identifying patients with COVID-19 in administrative claims data, and coordinated with other national and international initiatives. Sentinel is poised to answer important questions about the natural history of COVID-19 and is positioned to use this information to study the use, safety, and potentially the effectiveness of medical products used for COVID-19 prevention and treatment.The US Food and Drug Administration's Sentinel System was established in 2009 to use routinely collected electronic health data for improving the national capability to assess post-market medical product safety. Over more than a decade, Sentinel has become an integral part of FDA's surveillance capabilities and has been used to conduct analyses that have contributed to regulatory decisions. FDA's role in the COVID-19 pandemic response has necessitated an expansion and enhancement of Sentinel. Here we describe how the Sentinel System has supported FDA's response to the COVID-19 pandemic. We highlight new capabilities developed, key data generated to date, and lessons learned, particularly with respect to working with inpatient electronic health record data. Early in the pandemic, Sentinel developed a multi-pronged approach to support FDA's anticipated data and analytic needs. It incorporated new data sources, created a rapidly refreshed database, developed protocols to assess the natural history of COVID-19, validated a diagnosis-code based algorithm for identifying patients with COVID-19 in administrative claims data, and coordinated with other national and international initiatives. Sentinel is poised to answer important questions about the natural history of COVID-19 and is positioned to use this information to study the use, safety, and potentially the effectiveness of medical products used for COVID-19 prevention and treatment. |
| Author | Rosen, Edward Nathwani, Neesha Ko, Jenice Billings, Monisha Maro, Judith C. Hou, Laura Kempner, Maria Sands, Kenneth Nolan, Bridget Coronel‐Moreno, Claudia Orr, Robert Attaya, Samuel Kluberg, Sheryl A. Nguyen, Michael Curtis, Linda Scarnecchia, Daniel Toh, Sengwee Reynolds, Juliane Varma, Neha Dal Pan, Gerald J. Lyons, Jennifer Shinde, Mayura Bradley, Marie C. Carbonari, Dena M. Ball, Robert Haffenreffer, Katherine Nandyala, Sampada Platt, Richard Paraoan, Dianne Gowda, Abinav Halbig, Christine Lee Burk, Jillian Mai, Alexander Poland, Russell E. Martinez, Ashley Her, Meg Klompas, Michael Horgan, Casie McLean, Laura Contreras, Tawil Perlin, Jonathan Carter, Suzanne Cosgrove, Austin Draper, Christine Jin, Robert Richard, Julie E. Cocoros, Noelle M. Measer, Gregory Noble, Jennifer Martin, Christopher Damon, Jolene Ochoa, Aileen Hennessy, Sean Fuller, Candace C. Back, Soowoo Kennedy, Adee Pratt, Natasha Peters, Alexander Ehrmann, Max Maynard, Amanda Nolan, Jamie Pishko, Allyson Vigeant, Justin Adimadhyam, Sruthi Mosley, Jolene Shockro, Laura Yih, W. Kath |
| AuthorAffiliation | 1 Department of Population Medicine Harvard Medical School and Harvard Pilgrim Health Care Institute Boston Massachusetts USA 3 Division of Infectious Diseases, Department of Medicine, and Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA 4 HCA Healthcare Nashville Tennessee USA 2 US Food and Drug Administration Silver Spring Maryland USA |
| AuthorAffiliation_xml | – name: 4 HCA Healthcare Nashville Tennessee USA – name: 2 US Food and Drug Administration Silver Spring Maryland USA – name: 3 Division of Infectious Diseases, Department of Medicine, and Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA – name: 1 Department of Population Medicine Harvard Medical School and Harvard Pilgrim Health Care Institute Boston Massachusetts USA |
| Author_xml | – sequence: 1 givenname: Noelle M. orcidid: 0000-0001-7090-2761 surname: Cocoros fullname: Cocoros, Noelle M. email: noelle_cocoros@harvardpilgrim.org organization: Harvard Medical School and Harvard Pilgrim Health Care Institute – sequence: 2 givenname: Candace C. surname: Fuller fullname: Fuller, Candace C. organization: Harvard Medical School and Harvard Pilgrim Health Care Institute – sequence: 3 givenname: Sruthi surname: Adimadhyam fullname: Adimadhyam, Sruthi organization: Harvard Medical School and Harvard Pilgrim Health Care Institute – sequence: 4 givenname: Robert orcidid: 0000-0002-1609-7420 surname: Ball fullname: Ball, Robert organization: US Food and Drug Administration – sequence: 5 givenname: Jeffrey S. surname: Brown fullname: Brown, Jeffrey S. organization: Harvard Medical School and Harvard Pilgrim Health Care Institute – sequence: 6 givenname: Gerald J. surname: Dal Pan fullname: Dal Pan, Gerald J. organization: US Food and Drug Administration – sequence: 7 givenname: Sheryl A. surname: Kluberg fullname: Kluberg, Sheryl A. organization: Harvard Medical School and Harvard Pilgrim Health Care Institute – sequence: 8 givenname: Vincent orcidid: 0000-0001-7955-0600 surname: Lo Re fullname: Lo Re, Vincent organization: Perelman School of Medicine, University of Pennsylvania – sequence: 9 givenname: Judith C. surname: Maro fullname: Maro, Judith C. organization: Harvard Medical School and Harvard Pilgrim Health Care Institute – sequence: 10 givenname: Michael surname: Nguyen fullname: Nguyen, Michael organization: US Food and Drug Administration – sequence: 11 givenname: Robert surname: Orr fullname: Orr, Robert organization: US Food and Drug Administration – sequence: 12 givenname: Dianne surname: Paraoan fullname: Paraoan, Dianne organization: US Food and Drug Administration – sequence: 13 givenname: Jonathan surname: Perlin fullname: Perlin, Jonathan organization: HCA Healthcare – sequence: 14 givenname: Russell E. surname: Poland fullname: Poland, Russell E. organization: HCA Healthcare – sequence: 15 givenname: Meighan Rogers surname: Driscoll fullname: Driscoll, Meighan Rogers organization: Harvard Medical School and Harvard Pilgrim Health Care Institute – sequence: 16 givenname: Kenneth surname: Sands fullname: Sands, Kenneth organization: HCA Healthcare – sequence: 17 givenname: Sengwee orcidid: 0000-0002-5160-0810 surname: Toh fullname: Toh, Sengwee organization: Harvard Medical School and Harvard Pilgrim Health Care Institute – sequence: 18 givenname: W. Katherine surname: Yih fullname: Yih, W. Katherine organization: Harvard Medical School and Harvard Pilgrim Health Care Institute – sequence: 19 givenname: Richard surname: Platt fullname: Platt, Richard organization: Harvard Medical School and Harvard Pilgrim Health Care Institute – sequence: 21 givenname: Gregory surname: Measer fullname: Measer, Gregory – sequence: 22 givenname: Austin surname: Cosgrove fullname: Cosgrove, Austin – sequence: 23 givenname: Edward surname: Rosen fullname: Rosen, Edward – sequence: 24 givenname: Katherine surname: Haffenreffer fullname: Haffenreffer, Katherine – sequence: 25 givenname: Maria surname: Kempner fullname: Kempner, Maria – sequence: 26 givenname: Soowoo surname: Back fullname: Back, Soowoo – sequence: 27 givenname: Casie surname: Horgan fullname: Horgan, Casie – sequence: 28 givenname: Robert surname: Jin fullname: Jin, Robert – sequence: 29 givenname: Christine surname: Draper fullname: Draper, Christine – sequence: 30 givenname: Jennifer surname: Lyons fullname: Lyons, Jennifer – sequence: 31 givenname: Mayura surname: Shinde fullname: Shinde, Mayura – sequence: 32 givenname: Ashley surname: Martinez fullname: Martinez, Ashley – sequence: 33 givenname: Laura surname: Hou fullname: Hou, Laura – sequence: 34 givenname: Jenice surname: Ko fullname: Ko, Jenice – sequence: 35 givenname: Jillian surname: Burk fullname: Burk, Jillian – sequence: 36 givenname: Jennifer surname: Noble fullname: Noble, Jennifer – sequence: 37 givenname: Meg surname: Her fullname: Her, Meg – sequence: 38 givenname: Adee surname: Kennedy fullname: Kennedy, Adee – sequence: 39 givenname: Juliane surname: Reynolds fullname: Reynolds, Juliane – sequence: 40 givenname: Max surname: Ehrmann fullname: Ehrmann, Max – sequence: 41 givenname: Bridget surname: Nolan fullname: Nolan, Bridget – sequence: 42 givenname: Amanda surname: Maynard fullname: Maynard, Amanda – sequence: 43 givenname: Christopher surname: Martin fullname: Martin, Christopher – sequence: 44 givenname: Jamie surname: Nolan fullname: Nolan, Jamie – sequence: 45 givenname: Alexander surname: Peters fullname: Peters, Alexander – sequence: 46 givenname: Samuel surname: Attaya fullname: Attaya, Samuel – sequence: 47 givenname: Neha surname: Varma fullname: Varma, Neha – sequence: 48 givenname: Abinav surname: Gowda fullname: Gowda, Abinav – sequence: 49 givenname: Joy surname: Kolonoski fullname: Kolonoski, Joy – sequence: 50 givenname: Julie E. surname: Richard fullname: Richard, Julie E. – sequence: 51 givenname: Laura surname: Shockro fullname: Shockro, Laura – sequence: 52 givenname: Tawil surname: Contreras fullname: Contreras, Tawil – sequence: 53 givenname: Christine Lee surname: Halbig fullname: Halbig, Christine Lee – sequence: 54 givenname: Claudia surname: Coronel‐Moreno fullname: Coronel‐Moreno, Claudia – sequence: 55 givenname: Neesha surname: Nathwani fullname: Nathwani, Neesha – sequence: 56 givenname: Linda surname: Curtis fullname: Curtis, Linda – sequence: 57 givenname: Alexander surname: Mai fullname: Mai, Alexander – sequence: 58 givenname: Daniel surname: Scarnecchia fullname: Scarnecchia, Daniel – sequence: 59 givenname: Sampada surname: Nandyala fullname: Nandyala, Sampada – sequence: 60 givenname: Justin surname: Vigeant fullname: Vigeant, Justin – sequence: 61 givenname: Suzanne surname: Carter fullname: Carter, Suzanne – sequence: 62 givenname: Jolene surname: Damon fullname: Damon, Jolene – sequence: 63 givenname: Jolene surname: Mosley fullname: Mosley, Jolene – sequence: 64 givenname: Monisha surname: Billings fullname: Billings, Monisha – sequence: 65 givenname: Natasha surname: Pratt fullname: Pratt, Natasha – sequence: 66 givenname: Marie C. surname: Bradley fullname: Bradley, Marie C. – sequence: 67 givenname: Allyson surname: Pishko fullname: Pishko, Allyson – sequence: 68 givenname: Dena M. surname: Carbonari fullname: Carbonari, Dena M. – sequence: 69 givenname: Sean surname: Hennessy fullname: Hennessy, Sean – sequence: 70 givenname: Laura surname: McLean fullname: McLean, Laura – sequence: 71 givenname: Michael surname: Klompas fullname: Klompas, Michael – sequence: 72 givenname: Aileen surname: Ochoa fullname: Ochoa, Aileen |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33797815$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kd1q2zAUx8XoWD822BMMwS7WXTiTZcuWdzEIyboVCh0k7FbI0nGj4EipZLf4bo_QZ-yTTE66r7LtRhKc3zn8z0_H6MA6Cwi9TMkkJYS-2-owYTQnT9BRSqoqSRkrD8Y3yxLOiuoQHYewJiTWqvwZOsyysip5yo7Qeopnl1_P5_ff7tIqHh6kHvC2r1uj8Apk261w6P0NmLaVVgEOQ-hg8x4vV4DPnNNYWo3nvr_CU70x1oTOy844-ybgBdjOWGjxYtfzHD1tZBvgxcN9gpZnH5ezz8nF5afz2fQiUXnGSUIlbXTdKKlzgKrhPJVMa94Uqip0ySgpgUhVNBoklXnNaq60lEXDmWxUzbMT9HY_trdbOdzKthVbbzbSDyIlYtQloi4x6orshz0bF96AVjGwl794J434s2LNSly5G8EpIzzP4oDThwHeXfcQOrExQcHoClwfxIgxTipCI_r6Ebp2vbfRRKQyVtCCZmmkXv2e6GeUHz8WgckeUN6F4KERynQ74zGgaf-24-mjhv_oSPborWlh-CcnvswXO_47bzfIFQ |
| CitedBy_id | crossref_primary_10_2196_59024 crossref_primary_10_1136_bmjmed_2022_000421 crossref_primary_10_1093_cid_ciac661 crossref_primary_10_1001_jama_2022_13072 crossref_primary_10_1002_jhm_13068 crossref_primary_10_1007_s40264_022_01158_3 crossref_primary_10_1093_jamia_ocac153 crossref_primary_10_1002_jrsm_1648 crossref_primary_10_1002_cpt_2979 crossref_primary_10_21032_jhis_2023_48_2_148 crossref_primary_10_4018_IJTD_288525 crossref_primary_10_1007_s40264_022_01170_7 crossref_primary_10_1371_journal_pone_0288284 crossref_primary_10_1177_18333583221104213 crossref_primary_10_1002_pds_5440 crossref_primary_10_1080_14760584_2023_2182294 crossref_primary_10_1007_s40264_022_01256_2 crossref_primary_10_1111_irv_12921 crossref_primary_10_1002_pds_5436 crossref_primary_10_2147_CLEP_S448980 crossref_primary_10_2196_40312 |
| Cites_doi | 10.1002/pds.2311 10.1056/NEJMp1014427 10.7326/0003-4819-151-5-200909010-00139 10.1002/cpt.320 10.1111/jth.14869 10.1002/pds.2336 10.3201/eid2109.141912 10.1002/pds.3908 10.1093/aje/kwy023 10.1016/j.thromres.2020.04.024 10.2105/AJPH.2018.304526 10.1056/NEJMp1809643 10.1016/j.thromres.2020.04.013 10.1097/CCM.0000000000002316 10.1093/jamiaopen/ooaa061 10.1097/MLR.0b013e3181d9919f 10.1111/irv.12598 10.1056/NEJMoa2021436 10.1093/infdis/jiw376 |
| ContentType | Journal Article |
| Contributor | Chai, Grace Stojanovic, Danijela Corey, Catherine Perez-Vilar, Silvia Hua, Wei Woods, Corinne Dutcher, Sarah K Kit, Brian |
| Contributor_xml | – sequence: 1 givenname: Catherine surname: Corey fullname: Corey, Catherine – sequence: 2 givenname: Grace surname: Chai fullname: Chai, Grace – sequence: 3 givenname: Sarah K surname: Dutcher fullname: Dutcher, Sarah K – sequence: 4 givenname: Wei surname: Hua fullname: Hua, Wei – sequence: 5 givenname: Brian surname: Kit fullname: Kit, Brian – sequence: 6 givenname: Silvia surname: Perez-Vilar fullname: Perez-Vilar, Silvia – sequence: 7 givenname: Danijela surname: Stojanovic fullname: Stojanovic, Danijela – sequence: 8 givenname: Corinne surname: Woods fullname: Woods, Corinne |
| Copyright | 2021 John Wiley & Sons Ltd. 2021 John Wiley & Sons, Ltd. |
| Copyright_xml | – notice: 2021 John Wiley & Sons Ltd. – notice: 2021 John Wiley & Sons, Ltd. |
| CorporateAuthor | And the FDA‐Sentinel COVID‐19 Working Group And the FDA-Sentinel COVID-19 Working Group |
| CorporateAuthor_xml | – name: And the FDA‐Sentinel COVID‐19 Working Group – name: And the FDA-Sentinel COVID-19 Working Group |
| DBID | AAYXX CITATION NPM 7TK K9. 7X8 5PM ADTOC UNPAY |
| DOI | 10.1002/pds.5240 |
| DatabaseName | CrossRef PubMed Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed CrossRef ProQuest Health & Medical Complete (Alumni) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology Public Health |
| DocumentTitleAlternate | Cocoros et al |
| EISSN | 1099-1557 |
| EndPage | 837 |
| ExternalDocumentID | 10.1002/pds.5240 PMC8250843 33797815 10_1002_pds_5240 PDS5240 |
| Genre | reviewArticle Journal Article Review |
| GrantInformation_xml | – fundername: HCA Healthcare – fundername: US Food and Drug Administration (Department of Health and Human Services Contract Number funderid: 75F40119D10037) – fundername: US Food and Drug Administration (Department of Health and Human Services Contract Number grantid: 75F40119D10037) |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA GWYGA H.X HF~ HGLYW HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES M6Q MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V8K W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WWP WXI WXSBR XG1 XV2 YCJ ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION NPM 7TK K9. 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c4380-2a2fdbfcad4ee9f881a5dd8f6c96d75207e0ac6fdea2a4b5b8cdaa6f85afcb83 |
| IEDL.DBID | UNPAY |
| ISSN | 1053-8569 1099-1557 |
| IngestDate | Sun Oct 26 04:10:16 EDT 2025 Tue Sep 30 16:51:02 EDT 2025 Fri Sep 05 09:29:23 EDT 2025 Tue Oct 07 05:52:19 EDT 2025 Thu Apr 03 07:02:32 EDT 2025 Wed Oct 01 05:03:29 EDT 2025 Thu Apr 24 22:56:10 EDT 2025 Wed Jan 22 16:30:05 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | COVID-19 real-time monitoring medical claims real-world data electronic health records surveillance |
| Language | English |
| License | 2021 John Wiley & Sons Ltd. This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4380-2a2fdbfcad4ee9f881a5dd8f6c96d75207e0ac6fdea2a4b5b8cdaa6f85afcb83 |
| Notes | Funding information HCA Healthcare; US Food and Drug Administration (Department of Health and Human Services Contract Number, Grant/Award Number: 75F40119D10037) The protocols described in the text have been posted to the Sentinel System website. One of the projects summarized was presented at ICPE 2020: Validation of Claims‐based Algorithms to Identify Hospitalized COVID‐19 Events within the FDA Sentinel System. Members of the FDA‐Sentinel COVID‐19 Working Group: Catherine Corey, MSPH; Grace Chai, PharmD; Sarah K. Dutcher, PhD; Wei Hua, MD; Brian Kit, MD; Silvia Perez‐Vilar, PhD; Danijela Stojanovic, PhD; Corinne Woods, MPH. Prior postings and presentation ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 Prior postings and presentation: The protocols described in the text have been posted to the Sentinel System website. One of the projects summarized was presented at ICPE 2020: Validation of Claims‐based Algorithms to Identify Hospitalized COVID‐19 Events within the FDA Sentinel System. Funding information HCA Healthcare; US Food and Drug Administration (Department of Health and Human Services Contract Number, Grant/Award Number: 75F40119D10037) |
| ORCID | 0000-0001-7090-2761 0000-0002-1609-7420 0000-0002-5160-0810 0000-0001-7955-0600 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.5240 |
| PMID | 33797815 |
| PQID | 2535626231 |
| PQPubID | 105383 |
| PageCount | 11 |
| ParticipantIDs | unpaywall_primary_10_1002_pds_5240 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8250843 proquest_miscellaneous_2508580902 proquest_journals_2535626231 pubmed_primary_33797815 crossref_citationtrail_10_1002_pds_5240 crossref_primary_10_1002_pds_5240 wiley_primary_10_1002_pds_5240_PDS5240 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | July 2021 |
| PublicationDateYYYYMMDD | 2021-07-01 |
| PublicationDate_xml | – month: 07 year: 2021 text: July 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Chichester, UK |
| PublicationPlace_xml | – name: Chichester, UK – name: England – name: Bethesda |
| PublicationTitle | Pharmacoepidemiology and drug safety |
| PublicationTitleAlternate | Pharmacoepidemiol Drug Saf |
| PublicationYear | 2021 |
| Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
| References | 2018; 187 2010; 48 2020; 3 2018; 108 2020 2020; 191 2018; 379 2015; 21 2017; 45 2020; 15 2016 2021; 384 2009; 151 2020; 12 2016; 214 2018; 12 2012; 21 2016; 25 2011; 364 2016; 99 2020; 18 e_1_2_7_6_1 US FDA (e_1_2_7_27_1) 2020 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 Sands KE (e_1_2_7_42_1) 2020; 15 e_1_2_7_26_1 Sands KE (e_1_2_7_41_1) 2020; 12 e_1_2_7_28_1 FRANCISCO EM (e_1_2_7_29_1) 2020 Reagan‐Udall Foundation COVID‐19 Evidence Accelerator (e_1_2_7_31_1) 2020 Reagan‐Udall Foundation COVID‐19 Evidence Accelerator (e_1_2_7_32_1) 2020 Reagan‐Udall Foundation COVID‐19 Evidence Accelerator (e_1_2_7_33_1) 2020 Reagan‐Udall Foundation COVID‐19 Evidence Accelerator (e_1_2_7_35_1) 2020 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_24_1 e_1_2_7_23_1 Reagan‐Udall Foundation COVID‐19 Evidence Accelerator (e_1_2_7_34_1) 2020 e_1_2_7_22_1 e_1_2_7_21_1 e_1_2_7_20_1 e_1_2_7_37_1 Reagan‐Udall Foundation COVID‐19 Evidence Accelerator (e_1_2_7_36_1) 2020 e_1_2_7_39_1 (e_1_2_7_38_1) 2020 |
| References_xml | – volume: 21 start-page: 9 issue: Suppl 1 year: 2012 end-page: 11 article-title: The US Food and Drug Administration's sentinel initiative: expanding the horizons of medical product safety publication-title: Pharmacoepidemiol Drug Saf – year: 2020 article-title: Coagulopathy assessment in patients with COVID‐19: a TriNetX analysis [internet] publication-title: Sentinel Initiative – volume: 45 start-page: e711 issue: 7 year: 2017 end-page: e714 article-title: Validation of intensive care and mechanical ventilation codes in Medicare data publication-title: Crit Care Med – year: 2020 article-title: Assessing data source characteristics in multi‐site analyses [internet] publication-title: Sentinel Initiative – volume: 99 start-page: 265 issue: 3 year: 2016 end-page: 268 article-title: The FDA's sentinel initiative—a comprehensive approach to medical product surveillance publication-title: Clin Pharmacol Ther – volume: 12 start-page: 1 year: 2020 end-page: 2 article-title: Changes in hospitalized coronavirus disease 2019 (COVID‐19) patient characteristics and resource use in a system of community hospitals in the United States publication-title: Infect Control Hosp Epidemiol – volume: 18 start-page: 1743 issue: 7 year: 2020 end-page: 1746 article-title: High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients publication-title: J Thromb Haemost – volume: 384 start-page: 693 issue: 8 year: 2021 end-page: 704 article-title: Dexamethasone in hospitalized patients with Covid‐19—preliminary report publication-title: N Engl J Med – volume: 379 start-page: 2091 issue: 22 year: 2018 end-page: 2093 article-title: The FDA sentinel initiative—an evolving National Resource publication-title: N Engl J Med – volume: 21 start-page: 23 year: 2012 end-page: 31 article-title: Design considerations, architecture, and use of the Mini‐Sentinel distributed data system: Use of the mini‐sentinel distributed database publication-title: Pharmacoepidemiol Drug Saf – volume: 187 start-page: 1269 issue: 6 year: 2018 end-page: 1276 article-title: Assessment of quadrivalent human papillomavirus vaccine safety using the self‐controlled tree‐temporal scan statistic signal‐detection method in the sentinel system publication-title: Am J Epidemiol – volume: 25 start-page: 481 issue: 5 year: 2016 end-page: 492 article-title: Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System publication-title: Pharmacoepidemiol Drug Saf – year: 2020 article-title: Risk of thromboembolic events with COVID‐19: a sentinel system investigation – update on methods [internet] publication-title: Sentinel Initiative – volume: 191 start-page: 9 year: 2020 end-page: 14 article-title: Venous and arterial thromboembolic complications in COVID‐19 patients admitted to an academic hospital in Milan publication-title: Italy Thromb Res – year: 2020 article-title: Descriptive assessment of coagulopathy among COVID‐19 patients: feasibility data review [internet] publication-title: Sentinel Initiative – volume: 12 start-page: 804 issue: 6 year: 2018 end-page: 807 article-title: Outpatient influenza antivirals in a distributed data network for influenza surveillance publication-title: Influenza Respir Viruses – year: 2016 – year: 2020 article-title: Defining COVID‐19 cohorts in real‐world data [internet] publication-title: Sentinel Initiative – year: 2020 article-title: Risk of thromboembolic events with COVID‐19: a sentinel system investigation – focus on endpoints [internet] publication-title: Sentinel Initiative – volume: 21 start-page: 1543 issue: 9 year: 2015 end-page: 1550 article-title: The US influenza hospitalization surveillance network publication-title: Emerg Infect Dis – volume: 364 start-page: 498 issue: 6 year: 2011 end-page: 499 article-title: Developing the Sentinel System—a national resource for evidence development publication-title: N Engl J Med – volume: 191 start-page: 145 year: 2020 end-page: 147 article-title: Incidence of thrombotic complications in critically ill ICU patients with COVID‐19 publication-title: Thromb Res – year: 2020 – volume: 108 start-page: S224 issue: S3 year: 2018 end-page: S226 article-title: Monitoring and assessment of medical countermeasures as part of a public health emergency response publication-title: Am J Public Health – volume: 48 start-page: S45 year: 2010 end-page: S51 article-title: Distributed health data networks: a practical and preferred approach to multi‐institutional evaluations of comparative effectiveness, safety, and quality of care publication-title: Med Care – volume: 15 start-page: 1 year: 2020 end-page: 7 article-title: Patient characteristics and admitting vital signs associated with coronavirus disease 2019 (COVID‐19)‐related mortality among patients admitted with noncritical illness publication-title: Infect Control Hosp Epidemiol – volume: 3 start-page: 500 year: 2020 end-page: 505 article-title: The FDA MyStudies app: a reusable platform for distributed clinical trials and real‐world evidence studies publication-title: JAMIA Open – volume: 151 start-page: 341 issue: 5 year: 2009 end-page: 344 article-title: Design of a National Distributed Health Data Network publication-title: Ann Intern Med – volume: 214 start-page: S380 issue: suppl 4 year: 2016 end-page: S385 article-title: Infectious disease surveillance in the big data era: towards faster and locally relevant systems publication-title: J Infect Dis – ident: e_1_2_7_3_1 doi: 10.1002/pds.2311 – ident: e_1_2_7_37_1 – ident: e_1_2_7_2_1 doi: 10.1056/NEJMp1014427 – ident: e_1_2_7_20_1 – year: 2020 ident: e_1_2_7_36_1 article-title: Coagulopathy assessment in patients with COVID‐19: a TriNetX analysis [internet] publication-title: Sentinel Initiative – ident: e_1_2_7_6_1 doi: 10.7326/0003-4819-151-5-200909010-00139 – ident: e_1_2_7_4_1 doi: 10.1002/cpt.320 – ident: e_1_2_7_23_1 doi: 10.1111/jth.14869 – ident: e_1_2_7_8_1 doi: 10.1002/pds.2336 – ident: e_1_2_7_26_1 doi: 10.3201/eid2109.141912 – volume-title: Coronavirus (COVID‐19) Update: FDA Issues Emergency Use Authorization for Potential COVID‐19 Treatment [Internet] year: 2020 ident: e_1_2_7_27_1 – ident: e_1_2_7_11_1 – ident: e_1_2_7_14_1 doi: 10.1002/pds.3908 – ident: e_1_2_7_15_1 doi: 10.1093/aje/kwy023 – ident: e_1_2_7_25_1 – ident: e_1_2_7_22_1 doi: 10.1016/j.thromres.2020.04.024 – ident: e_1_2_7_12_1 doi: 10.2105/AJPH.2018.304526 – ident: e_1_2_7_17_1 – year: 2020 ident: e_1_2_7_34_1 article-title: Risk of thromboembolic events with COVID‐19: a sentinel system investigation – focus on endpoints [internet] publication-title: Sentinel Initiative – ident: e_1_2_7_5_1 doi: 10.1056/NEJMp1809643 – year: 2020 ident: e_1_2_7_31_1 article-title: Descriptive assessment of coagulopathy among COVID‐19 patients: feasibility data review [internet] publication-title: Sentinel Initiative – ident: e_1_2_7_10_1 – ident: e_1_2_7_21_1 doi: 10.1016/j.thromres.2020.04.013 – volume-title: ACTIV [Internet] year: 2020 ident: e_1_2_7_38_1 – ident: e_1_2_7_39_1 doi: 10.1097/CCM.0000000000002316 – ident: e_1_2_7_13_1 – ident: e_1_2_7_24_1 – ident: e_1_2_7_30_1 doi: 10.1093/jamiaopen/ooaa061 – year: 2020 ident: e_1_2_7_35_1 article-title: Risk of thromboembolic events with COVID‐19: a sentinel system investigation – update on methods [internet] publication-title: Sentinel Initiative – ident: e_1_2_7_19_1 – ident: e_1_2_7_7_1 doi: 10.1097/MLR.0b013e3181d9919f – year: 2020 ident: e_1_2_7_33_1 article-title: Defining COVID‐19 cohorts in real‐world data [internet] publication-title: Sentinel Initiative – volume: 15 start-page: 1 year: 2020 ident: e_1_2_7_42_1 article-title: Patient characteristics and admitting vital signs associated with coronavirus disease 2019 (COVID‐19)‐related mortality among patients admitted with noncritical illness publication-title: Infect Control Hosp Epidemiol – ident: e_1_2_7_18_1 – year: 2020 ident: e_1_2_7_32_1 article-title: Assessing data source characteristics in multi‐site analyses [internet] publication-title: Sentinel Initiative – ident: e_1_2_7_9_1 – ident: e_1_2_7_16_1 doi: 10.1111/irv.12598 – volume-title: COVID‐19: EMA sets up infrastructure for real‐world monitoring of treatments and vaccines [Internet] year: 2020 ident: e_1_2_7_29_1 – volume: 12 start-page: 1 year: 2020 ident: e_1_2_7_41_1 article-title: Changes in hospitalized coronavirus disease 2019 (COVID‐19) patient characteristics and resource use in a system of community hospitals in the United States publication-title: Infect Control Hosp Epidemiol – ident: e_1_2_7_28_1 doi: 10.1056/NEJMoa2021436 – ident: e_1_2_7_40_1 doi: 10.1093/infdis/jiw376 |
| SSID | ssj0009994 |
| Score | 2.4326775 |
| SecondaryResourceType | review_article |
| Snippet | The US Food and Drug Administration's Sentinel System was established in 2009 to use routinely collected electronic health data for improving the national... |
| SourceID | unpaywall pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 827 |
| SubjectTerms | COVID-19 electronic health records Electronic medical records Health surveillance medical claims Medical equipment Pandemics Public health real‐time monitoring real‐world data Review Reviews surveillance |
| SummonAdditionalLinks | – databaseName: Wiley Online Library - Core collection (SURFmarket) dbid: DR2 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3LjtMwFIYtNBvYcL8EBmQQ6mwmnVxsN2E3mlINSEDFFDQSi-g4todLlVZNAyorHoFn5Ek4jpNUYQAhNs0iJ26d_if-kxx_JuSxkugDlA78AHTsM26YD4phXsWKp6EMIAX7vOPFS3H8hj0_5adNVaWdC-P4EN0DN5sZ9fXaJjjI8mALDV2qcshxPMLLbxiL-m7q9ZYchb6nfqGMGvMTLtKWOxtEB-2B_ZHonL08XyV5sSqWsPkC83nfydZD0eQKedd2wlWgfBpWaznMv_7Cd_y_Xl4llxuHSg-dpK6RC7q4TgZTh7je7NPZdsZWuU8HdLqFX29ukI-H9OjV22fjH9--hyl-oCdVG-pg2tRNuqRltfqs7WpHKDjqUNJPbLN0slgoCoWi41V1Rvtc372SntjKJuwQdZj1m2Q2eTo7Ovab9Rz83HLt_Qgio6TJUQxapyZJQuBKJUbkqVAjHgUjHUAujNIQAZNcJrkCECbhYHKZxLfITrEo9B1CDUtBoPYED2PGUpUqzSQIZQzHATkPPLLX_rVZ3rDO7ZIb88xRmqMMz2tmz6tHHnaRS8f3-E3MbquOrMnwMot4jNYRzWOITXS7MTftCxco9KKyMWhoE1v56pHbTkzdl8TxyOLGuEdGPZl1AZb73d9TfHhf878T2y6LPfKoE-RffvugltcfA7Lp-MRu7_5r4D1yKbJ1PXXJ8i7ZWa8qfR-N2Vo-qFPwJ5zpOy0 priority: 102 providerName: Wiley-Blackwell |
| Title | A COVID‐19‐ready public health surveillance system: The Food and Drug Administration's Sentinel System |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpds.5240 https://www.ncbi.nlm.nih.gov/pubmed/33797815 https://www.proquest.com/docview/2535626231 https://www.proquest.com/docview/2508580902 https://pubmed.ncbi.nlm.nih.gov/PMC8250843 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.5240 |
| UnpaywallVersion | publishedVersion |
| Volume | 30 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1053-8569 databaseCode: DR2 dateStart: 19960101 customDbUrl: isFulltext: true eissn: 1099-1557 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009994 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD6C7gFexh0CYzIIdS9LlYudC2_VSjWQGBXr0HiK7NiGQZVWTQMqT_wEfiO_hOM4zQgDhHhJpPjEiZPv5Hyxjz8DPJECeYBUnutxFbqUaepySdGvQslSX3g85aa_4-VRdHhCX5yy06bDzcyFsfoQbYeb8Yz6e20cfCG1_c43o_sBHikHDGPSZdiKGHLxHmydHE2Gb-shTha6CavXtDOjPy4GznijPvvTqd14dIFkXsyVvFIVC77-zGezLp-tA9L4GmSbptg8lI-DaiUG-ZdfVB7_v63XYbvhqmRowXUDLqniJvQnVux6vU-m53O3yn3SJ5NzGez1LfgwJAev3jwfff_6zU9xg-xUromV1SZ2-iUpq-UnZdY9QugRKyr91FRLxvO5JLyQZLSs3pGuwu9eSY5NjhM2iljB9dswHT-bHhy6zcoObm4U7t2AB1oKnSMslEp1kvicSZnoKE8jGbPAi5XH80hLxQNOBRNJLjmPdMK4zkUS3oFeMS_UPSCapjxCFEbMDylNZSoVFTySWjMMzbnnwN7m9WZ5o3puFt-YZVavOcjwuWbmuTrwqLVcWKWP39jsbBCSNb5eZgELkUQijfSxirYYvdQMvfBCzStjg9Q2MTmwDty1gGovEoaxER5jDsQdqLUGRgG8W1Kcva-VwBNTLw0deNyC8i_33q8h9keDbDI6Nvv7_1LbA7gamOyeOnF5B3qrZaUeIj1biV38MXkd7Dae-AOQVEC9 |
| linkProvider | Unpaywall |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1db9MwFIaPxrgYN-MbAgMMQt3N0uXDdhO4mlaqDrZRsQ7tAilyYnt8VGnVNqByxU_gN_JLOI6bVGGAEDftRU7cOnlP_dY5fgzwVKboA6TyXE-o0KVMU1dIinkVShb7qSdiYeY7jo55_5S-PGNna_C8Wgtj-RD1hJvJjPL32iS4mZDeXVFDJ3LWZjggXYLLlOPfFOOI3qzYUeh8ykfKqDI3YjyuyLNesFud2RyLLhjMi3WSG0U-EYsvYjRqetlyMOpdhXdVN2wNyqd2MU_b2ddfCI__2c9rsLk0qWTPquo6rKn8BrQGlnK92CHD1aKt2Q5pkcGKf724CR_3yP7rtwfdH9---zG-oC2VC2J52sSuuySzYvpZmQ2PUHPE0qSfmWZJbzyWROSSdKfFOWmifbdn5MQUN2GPiCWt34Jh78Vwv-8ut3RwM4O2dwMRaJnqDPWgVKyjyBdMykjzLOaywwKvozyRcS2VCARNWRplUgiuIyZ0lkbhbVjPx7m6C0TTWHCUH2d-SGksY6loKrjUmuGYnHkObFf3NsmWuHOz68YosaDmIMHrmpjr6sDjOnJiER-_idmq5JEsk3yWBCxE94j-0ccm6sOYnuaZi8jVuDAx6GkjU_zqwB2rpvpDwrBjiGPMgU5DZ3WAQX83j-Qf3pcI8Mi0S0MHntSK_Mt3b5X6-mNAMuiemPd7_xr4CDb6w6PD5PDg-NV9uBKYMp-ygnkL1ufTQj1AnzZPH5b5-BMjjD9O |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1db9MwFIaPxpBgN3zDAgMMQt3N0uXDTm24mhaqjY9RsQ7tAilyYhs2qrRqGqbuip_Ab-SXYMdNqjBAiJv0IqdOnL6nfuUcPwZ4JlLtA4T0XI_L0MVEYZcLrPMqFIT5qccZN_Mdbw-ivSP86pgcr8CLei2M5UM0E24mM6r_a5PgciLU9pIaOhFFl-gB6RJcxoRRU88Xv1-yo7TzqV4pa5W5lESsJs96wXb9zfZYdMFgXqyTvFrmEz4_46NR28tWg1H_Onysu2FrUL50y1nazc5_ITz-Zz9vwLWFSUU7VlU3YUXmt6AzsJTr-RYaLhdtFVuogwZL_vX8NpzuoN13H_bjH9---0wftC0Vc2R52siuu0RFOf0qzYZHWnPI0qSfm2ZRfzwWiOcCxdPyE2qjfTcLdGiKm3SPkCWt34Fh_-Vwd89dbOngZgZt7wY8UCJVmdaDlExR6nMiBFVRxiLRI4HXkx7PIiUkDzhOSUozwXmkKOEqS2l4F1bzcS7XASnMeKTlFxE_xJgJJiROeSSUInpMzjwHNuvfNskWuHOz68YosaDmINHPNTHP1YEnTeTEIj5-E7NRyyNZJHmRBCTU7lH7R1830ZzW6WneufBcjksToz0tNcWvDtyzamouEoY9QxwjDvRaOmsCDPq7fSY_-VwhwKlpF4cOPG0U-Zd771T6-mNAMogPzef9fw18DFcGcT95s3_w-gGsBabKpypg3oDV2bSUD7VNm6WPqnT8CXmqPtI |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB5B9wAX3o_AggxC3cumysPOg1u1pVqQWCptFy2nyIltXlVatQ2onPgJ_EZ-CTNxmiUsIMQlkeKJEzvfZD7Z488AT1SOPEBpz_WkDl0uDHel4uhXoRKpn3sylTTe8fIoOjzhL07FaTPgRmthrD5EO-BGnlH_r8nBF8rY_3wzux_gldVAYEy6CDuRQC7eg52To8nwTT3FKUI3EfWedjT742LgjLfqsz_d2o1H50jm-VzJS1W5kJvPcjbr8tk6II2vQrZtis1D-Tio1vmg-PKLyuP_t_UaXGm4KhtacF2HC7q8Af2JFbve7LPp2dqt1T7rs8mZDPbmJnwYsoNXr5-Pvn_95qd4QHaqNszKajO7_JKtquUnTfseIfSYFZV-StWy8XyumCwVGy2rt6yr8Lu3YseU44SNYlZw_RZMx8-mB4dus7ODW5DCvRvIwKjcFAgLrVOTJL4USiUmKtJIxSLwYu3JIjJKy0DyXORJoaSMTCKkKfIkvA29cl7qu8AMT2WEKIyEH3KeqlRpnstIGSMwNBeeA3vbz5sVjeo5bb4xy6xec5Bhv2bUrw48ai0XVunjNza7W4Rkja-vskCESCKRRvpYRVuMXkpTL7LU84pskNomlAPrwB0LqPYhYRiT8JhwIO5ArTUgBfBuSfn-Xa0EnlC9PHTgcQvKv7x7v4bYHw2yyeiYzvf-pbb7cDmg7J46cXkXeutlpR8gPVvnDxsf_AERwz_U |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+COVID+%E2%80%9019%E2%80%90ready+public+health+surveillance+system%3A+The+Food+and+Drug+Administration%27s+Sentinel+System&rft.jtitle=Pharmacoepidemiology+and+drug+safety&rft.au=Cocoros%2C+Noelle+M.&rft.au=Fuller%2C+Candace+C.&rft.au=Adimadhyam%2C+Sruthi&rft.au=Ball%2C+Robert&rft.date=2021-07-01&rft.issn=1053-8569&rft.eissn=1099-1557&rft.volume=30&rft.issue=7&rft.spage=827&rft.epage=837&rft_id=info:doi/10.1002%2Fpds.5240&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_pds_5240 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-8569&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-8569&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-8569&client=summon |